Faye S Silverstein1, Beth S Slomine, James Christensen, Richard Holubkov, Kent Page, J Michael Dean, Frank W Moler. 1. 1Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.2Department of Neuropsychology, Kennedy Krieger Institute, Baltimore, MD.3Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD.4Department of Pediatric Rehabilitation Medicine, Kennedy Krieger Institute, Baltimore, MD.5Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD.6Department of Pediatrics, University of Utah, Salt Lake City, Utah.
Abstract
OBJECTIVES: To analyze functional performance measures collected prospectively during the conduct of a clinical trial that enrolled children (up to age 18 yr old), resuscitated after out-of-hospital cardiac arrest, who were at high risk of poor outcomes. DESIGN: Children with Glasgow Motor Scale score less than 5, within 6 hours of resuscitation, were enrolled in a clinical trial that compared two targeted temperature management interventions (THAPCA-OH, NCT00878644). The primary outcome, 12-month survival with Vineland Adaptive Behavior Scale, second edition, score greater or equal to 70, did not differ between groups. SETTING: Thirty-eight North American PICUs. PARTICIPANTS: Two hundred ninety-five children were enrolled; 270 of 295 had baseline Vineland Adaptive Behavior Scale, second edition, scores greater or equal to 70; 87 of 270 survived 1 year. INTERVENTIONS: Targeted temperatures were 33.0°C and 36.8°C for hypothermia and normothermia groups. MEASUREMENTS AND MAIN RESULTS: Baseline measures included Vineland Adaptive Behavior Scale, second edition, Pediatric Cerebral Performance Category, and Pediatric Overall Performance Category. Pediatric Cerebral Performance Category and Pediatric Overall Performance Category were rescored at hospital discharges; all three were scored at 3 and 12 months. In survivors with baseline Vineland Adaptive Behavior Scale, second edition scores greater or equal to 70, we evaluated relationships of hospital discharge Pediatric Cerebral Performance Category with 3- and 12-month scores and between 3- and 12-month Vineland Adaptive Behavior Scale, second edition, scores. Hospital discharge Pediatric Cerebral Performance Category scores strongly predicted 3- and 12-month Pediatric Cerebral Performance Category (r = 0.82 and 0.79; p < 0.0001) and Vineland Adaptive Behavior Scale, second edition, scores (r = -0.81 and -0.77; p < 0.0001). Three-month Vineland Adaptive Behavior Scale, second edition, scores strongly predicted 12-month performance (r = 0.95; p < 0.0001). Hypothermia treatment did not alter these relationships. CONCLUSIONS: In comatose children, with Glasgow Motor Scale score less than 5 in the initial hours after out-of-hospital cardiac arrest resuscitation, function scores at hospital discharge and at 3 months predicted 12-month performance well in the majority of survivors.
OBJECTIVES: To analyze functional performance measures collected prospectively during the conduct of a clinical trial that enrolled children (up to age 18 yr old), resuscitated after out-of-hospital cardiac arrest, who were at high risk of poor outcomes. DESIGN:Children with Glasgow Motor Scale score less than 5, within 6 hours of resuscitation, were enrolled in a clinical trial that compared two targeted temperature management interventions (THAPCA-OH, NCT00878644). The primary outcome, 12-month survival with Vineland Adaptive Behavior Scale, second edition, score greater or equal to 70, did not differ between groups. SETTING: Thirty-eight North American PICUs. PARTICIPANTS: Two hundred ninety-five children were enrolled; 270 of 295 had baseline Vineland Adaptive Behavior Scale, second edition, scores greater or equal to 70; 87 of 270 survived 1 year. INTERVENTIONS: Targeted temperatures were 33.0°C and 36.8°C for hypothermia and normothermia groups. MEASUREMENTS AND MAIN RESULTS: Baseline measures included Vineland Adaptive Behavior Scale, second edition, Pediatric Cerebral Performance Category, and Pediatric Overall Performance Category. Pediatric Cerebral Performance Category and Pediatric Overall Performance Category were rescored at hospital discharges; all three were scored at 3 and 12 months. In survivors with baseline Vineland Adaptive Behavior Scale, second edition scores greater or equal to 70, we evaluated relationships of hospital discharge Pediatric Cerebral Performance Category with 3- and 12-month scores and between 3- and 12-month Vineland Adaptive Behavior Scale, second edition, scores. Hospital discharge Pediatric Cerebral Performance Category scores strongly predicted 3- and 12-month Pediatric Cerebral Performance Category (r = 0.82 and 0.79; p < 0.0001) and Vineland Adaptive Behavior Scale, second edition, scores (r = -0.81 and -0.77; p < 0.0001). Three-month Vineland Adaptive Behavior Scale, second edition, scores strongly predicted 12-month performance (r = 0.95; p < 0.0001). Hypothermia treatment did not alter these relationships. CONCLUSIONS: In comatosechildren, with Glasgow Motor Scale score less than 5 in the initial hours after out-of-hospital cardiac arrest resuscitation, function scores at hospital discharge and at 3 months predicted 12-month performance well in the majority of survivors.
Authors: Gavin D Perkins; Ian G Jacobs; Vinay M Nadkarni; Robert A Berg; Farhan Bhanji; Dominique Biarent; Leo L Bossaert; Stephen J Brett; Douglas Chamberlain; Allan R de Caen; Charles D Deakin; Judith C Finn; Jan-Thorsten Gräsner; Mary Fran Hazinski; Taku Iwami; Rudolph W Koster; Swee Han Lim; Matthew Huei-Ming Ma; Bryan F McNally; Peter T Morley; Laurie J Morrison; Koenraad G Monsieurs; William Montgomery; Graham Nichol; Kazuo Okada; Marcus Eng Hock Ong; Andrew H Travers; Jerry P Nolan Journal: Circulation Date: 2014-11-11 Impact factor: 29.690
Authors: Lance B Becker; Tom P Aufderheide; Romergryko G Geocadin; Clifton W Callaway; Ronald M Lazar; Michael W Donnino; Vinay M Nadkarni; Benjamin S Abella; Christophe Adrie; Robert A Berg; Raina M Merchant; Robert E O'Connor; David O Meltzer; Margo B Holm; William T Longstreth; Henry R Halperin Journal: Circulation Date: 2011-10-03 Impact factor: 29.690
Authors: Frank W Moler; Amy E Donaldson; Kathleen Meert; Richard J Brilli; Vinay Nadkarni; Donald H Shaffner; Charles L Schleien; Robert S B Clark; Heidi J Dalton; Kimberly Statler; Kelly S Tieves; Richard Hackbarth; Robert Pretzlaff; Elise W van der Jagt; Jose Pineda; Lynn Hernan; J Michael Dean Journal: Crit Care Med Date: 2011-01 Impact factor: 7.598
Authors: Richard Holubkov; Amy E Clark; Frank W Moler; Beth S Slomine; James R Christensen; Faye S Silverstein; Kathleen L Meert; Murray M Pollack; J Michael Dean Journal: Pediatr Crit Care Med Date: 2015-01 Impact factor: 3.624
Authors: Beth S Slomine; Melissa L McCarthy; Ru Ding; Ellen J MacKenzie; Kenneth M Jaffe; Mary E Aitken; Dennis R Durbin; James R Christensen; Andrea M Dorsch; Charles N Paidas Journal: Pediatrics Date: 2006-03-13 Impact factor: 7.124
Authors: Frank W Moler; Kathleen Meert; Amy E Donaldson; Vinay Nadkarni; Richard J Brilli; Heidi J Dalton; Robert S B Clark; Donald H Shaffner; Charles L Schleien; Kimberly Statler; Kelly S Tieves; Richard Hackbarth; Robert Pretzlaff; Elise W van der Jagt; Fiona Levy; Lynn Hernan; Faye S Silverstein; J Michael Dean Journal: Crit Care Med Date: 2009-07 Impact factor: 7.598
Authors: Frank W Moler; Faye S Silverstein; Richard Holubkov; Beth S Slomine; James R Christensen; Vinay M Nadkarni; Kathleen L Meert; Amy E Clark; Brittan Browning; Victoria L Pemberton; Kent Page; Seetha Shankaran; Jamie S Hutchison; Christopher J L Newth; Kimberly S Bennett; John T Berger; Alexis Topjian; Jose A Pineda; Joshua D Koch; Charles L Schleien; Heidi J Dalton; George Ofori-Amanfo; Denise M Goodman; Ericka L Fink; Patrick McQuillen; Jerry J Zimmerman; Neal J Thomas; Elise W van der Jagt; Melissa B Porter; Michael T Meyer; Rick Harrison; Nga Pham; Adam J Schwarz; Jeffrey E Nowak; Jeffrey Alten; Derek S Wheeler; Utpal S Bhalala; Karen Lidsky; Eric Lloyd; Mudit Mathur; Samir Shah; Theodore Wu; Andreas A Theodorou; Ronald C Sanders; J Michael Dean Journal: N Engl J Med Date: 2015-04-25 Impact factor: 91.245
Authors: Frank W Moler; Faye S Silverstein; Kathleen L Meert; Amy E Clark; Richard Holubkov; Brittan Browning; Beth S Slomine; James R Christensen; J Michael Dean Journal: Pediatr Crit Care Med Date: 2013-09 Impact factor: 3.624
Authors: Rebecca Ichord; Faye S Silverstein; Beth S Slomine; Russell Telford; James Christensen; Richard Holubkov; J Michael Dean; Frank W Moler Journal: Neurology Date: 2018-06-08 Impact factor: 9.910
Authors: Cydni N Williams; Mary E Hartman; Kristin P Guilliams; Rejean M Guerriero; Juan A Piantino; Christopher C Bosworth; Skyler S Leonard; Kathryn Bradbury; Amanda Wagner; Trevor A Hall Journal: Curr Treat Options Neurol Date: 2019-09-27 Impact factor: 3.598
Authors: Beth S Slomine; Faye S Silverstein; James R Christensen; Kent Page; Richard Holubkov; J Michael Dean; Frank W Moler Journal: JAMA Neurol Date: 2018-12-01 Impact factor: 18.302
Authors: Beth S Slomine; Vinay M Nadkarni; James R Christensen; Faye S Silverstein; Russell Telford; Alexis Topjian; Joshua D Koch; Jill Sweney; Ericka L Fink; Mudit Mathur; Richard Holubkov; J Michael Dean; Frank W Moler Journal: Resuscitation Date: 2017-03-06 Impact factor: 5.262
Authors: Kathleen Meert; Beth S Slomine; James R Christensen; Russell Telford; Richard Holubkov; J Michael Dean; Frank W Moler Journal: Resuscitation Date: 2018-03-27 Impact factor: 5.262
Authors: Mioara D Manole; Marcus J A Hook; Melissa A Nicholas; Brittany P Nelson; Adanna C Liu; Quinn C Stezoski; Andrew P Rowley; Jeffrey P Cheng; Henry Alexander; Eleni H Moschonas; Corina O Bondi; Anthony E Kline Journal: Exp Neurol Date: 2020-11-02 Impact factor: 5.330
Authors: Matthew P Kirschen; Daniel J Licht; Jennifer Faerber; Antara Mondal; Kathryn Graham; Madeline Winters; Ramani Balu; Ramon Diaz-Arrastia; Robert A Berg; Alexis Topjian; Arastoo Vossough Journal: Neurology Date: 2020-11-18 Impact factor: 9.910